Literature DB >> 8891776

Screening for chronic beryllium disease using beryllium specific lymphocyte proliferation testing.

T N Markham1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8891776     DOI: 10.1007/bf00377860

Source DB:  PubMed          Journal:  Int Arch Occup Environ Health        ISSN: 0340-0131            Impact factor:   3.015


× No keyword cloud information.
  6 in total

1.  Delayed chemical pneumonitis occurring in workers exposed to beryllium compounds.

Authors:  H L HARDY; I R TABERSHAW
Journal:  J Ind Hyg Toxicol       Date:  1946-09

2.  Screening blood test identifies subclinical beryllium disease.

Authors:  K Kreiss; L S Newman; M M Mroz; P A Campbell
Journal:  J Occup Med       Date:  1989-07

3.  In vitro studies on granulomatous hypersensitivity to beryllium.

Authors:  J M Hanifin; W L Epstein; M J Cline
Journal:  J Invest Dermatol       Date:  1970-10       Impact factor: 8.551

Review 4.  Chronic beryllium disease--from the workplace to cellular immunology, molecular immunogenetics, and back.

Authors:  K Kreiss; F Miller; L S Newman; E A Ojo-Amaize; M D Rossman; C Saltini
Journal:  Clin Immunol Immunopathol       Date:  1994-05

5.  Bronchoalveolar lavage in a patient with chronic berylliosis: evidence for hypersensitivity pneumonitis.

Authors:  P E Epstein; J H Dauber; M D Rossman; R P Daniele
Journal:  Ann Intern Med       Date:  1982-08       Impact factor: 25.391

6.  Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history.

Authors:  L S Newman; K Kreiss; T E King; S Seay; P A Campbell
Journal:  Am Rev Respir Dis       Date:  1989-06
  6 in total
  2 in total

Review 1.  Clinical application of beryllium lymphocyte proliferation testing.

Authors:  Barbara P Barna; Daniel A Culver; Belinda Yen-Lieberman; Raed A Dweik; Mary Jane Thomassen
Journal:  Clin Diagn Lab Immunol       Date:  2003-11

2.  Long-term follow-up of beryllium sensitized workers from a single employer.

Authors:  Mona Duggal; David C Deubner; Anne M Curtis; Mark R Cullen
Journal:  BMC Public Health       Date:  2010-01-04       Impact factor: 3.295

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.